Fox News - Fair & Balanced

Amylin Pharmaceuticals

More Headlines »« Less Headlines

RelatedTopics

  1. Metformin
  2. Ray Kelly
  3. John York
  4. Leaders in Tech
  5. Joe Banner
  6. Columbia Pictures
Get updates on Amylin Pharmaceuticals
WSJ: Bristol-Myers Eyeing Amylin Pharmaceuticals

FBN’s Robert Gray on reports Bristol-Myers is still considering acquiring Amylin Pharmaceuticals .

Read More ›

  1. Did intelligence agencies mishandle Boston?

    KT McFarland offers her analysis

  2. Icahn Calls for Amylin Chair to Step Down

    Exclusive: A one-on-one interview with billionaire investor Carl Icahn.

  3. GlaxoSmithKline set for $2.8 billion Human Genome takeover

    GlaxoSmithKline is expected to announce a deal to buy Human Genome Sciences for about $2.8 billion as soon as Monday, ending a three-month hostile pursuit of the U.S...

  4. GSK says new data support filing of diabetes drug

    GlaxoSmithKline will push ahead with plans to file its experimental once-weekly diabetes drug albiglutide for regulatory approval, following the read-out from a seri...

  5. WSJ: Delta Airlines Wants to Pump Its Own Fuel

    FBN's Lauren Simonetti breaks down late-morning market news.

  6. FDA may fine Merck for lack of study on diabetes drugs

    U.S. drug regulators may fine Merck for failing to test whether its diabetes drugs Januvia and Janumet can raise the risk of an inflamed pancreas, according to a war...

  7. Lilly CEO: On Verge of Scientific Advance

    Exclusive: Eli Lilly CEO John Lechleiter on government proposed health care reform, funding for biomedical innovations, and what it will mean to the industry.

  8. Q&A: Why Is Avandia's Safety in Doubt?

    European and U.S. drugs regulators will decide on Thursday whether GlaxoSmithKline Plc's diabetes drug Avandia should be pulled from the market due to concerns about...

  9. Study: Type 2 Diabetes Raises Risk of Pancreatitis

    People with type 2 diabetes have an almost three-fold higher risk of acute pancreatitis (inflammation of the pancreas) and two-fold greater risk of biliary disease (...

  10. Stocks to Watch: Microsoft, Verizon, Exxon Mobil

    Among the companies whose shares are expected to see active trade in Thursday's session are Microsoft Corp., Verizon Communications, Exxon Mobil Corp. and Siebel Sys...

  11. GSK files for US approval of new diabetes drug

    GlaxoSmithKline said on Monday it had filed for U.S. approval of its new once-weekly diabetes drug albiglutide and would make a similar submission shortly in Europe ...

  12. Full episode: 'Red Eye' 8/23/12

    Sandra Smith, Andrea Tantaros and Gavin McInnes discuss the RNC, DNC conventions

  1. Barbara Corcoran: Brooklyn is the New Manhattan

    Real estate mogul Barbara Corcoran on New York City real estate and why Brooklyn is heating up.

  2. Amylin , Lilly End Ill-Fated Linkup

    Eli Lilly & Co. and Amylin Pharmaceuticals Inc. severed a nine-year-old partnership that was supposed to furnish a blockbuster treatment for diabetes but was instead...

  3. Amylin's once-a-week diabetes injection wins FDA approval after 2 previous rejections

    Amylin Pharmaceuticals won approval Friday for its long-delayed diabetes drug Bydureon, a next-generation treatment that requires fewer injections than the company's...

  4. Carl Icahn Sues Amylin

    FBN’s Robert Gray on Carl Icahn suing Amylin for more time to nominate directors to help pressure the company to accept a takeover bid.

  5. FNC Video

    null

  6. Reaction to reports on Boston bombers' original plans

    Former NYPD detective speaks out

  7. Boston bombing suspect held in small cell with steel door

    David Lee Miller reports from Boston, Mass.

‹ Prev123Next ›